Literature DB >> 29531056

DEC2 modulates orexin expression and regulates sleep.

Arisa Hirano1, Pei-Ken Hsu1, Luoying Zhang1, Lijuan Xing1, Thomas McMahon1, Maya Yamazaki1, Louis J Ptáček2,3,4,5, Ying-Hui Fu2,3,4.   

Abstract

Adequate sleep is essential for physical and mental health. We previously identified a missense mutation in the human DEC2 gene (BHLHE41) leading to the familial natural short sleep behavioral trait. DEC2 is a transcription factor regulating the circadian clock in mammals, although its role in sleep regulation has been unclear. Here we report that prepro-orexin, also known as hypocretin (Hcrt), gene expression is increased in the mouse model expressing the mutant hDEC2 transgene (hDEC2-P384R). Prepro-orexin encodes a precursor protein of a neuropeptide producing orexin A and B (hcrt1 and hcrt2), which is enriched in the hypothalamus and regulates maintenance of arousal. In cell culture, DEC2 suppressed prepro-orexin promoter-luc (ore-luc) expression through cis-acting E-box elements. The mutant DEC2 has less repressor activity than WT-DEC2, resulting in increased orexin expression. DEC2-binding affinity for the prepro-orexin gene promoter is decreased by the P384R mutation, likely due to weakened interaction with other transcription factors. In vivo, the decreased immobility time of the mutant transgenic mice is attenuated by an orexin receptor antagonist. Our results suggested that DEC2 regulates sleep/wake duration, at least in part, by modulating the neuropeptide hormone orexin.

Entities:  

Keywords:  behavior; genetics; mouse model; sleep

Mesh:

Substances:

Year:  2018        PMID: 29531056      PMCID: PMC5879715          DOI: 10.1073/pnas.1801693115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial.

Authors:  David Michelson; Ellen Snyder; Erin Paradis; Mary Chengan-Liu; Duane B Snavely; Jill Hutzelmann; James K Walsh; Andrew D Krystal; Ruth M Benca; Martin Cohn; Christopher Lines; Thomas Roth; W Joseph Herring
Journal:  Lancet Neurol       Date:  2014-03-27       Impact factor: 44.182

Review 2.  Overview of orexin/hypocretin system.

Authors:  Michihiro Mieda; Takeshi Sakurai
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

3.  Modeling of a human circadian mutation yields insights into clock regulation by PER2.

Authors:  Y Xu; K L Toh; C R Jones; J-Y Shin; Y-H Fu; L J Ptácek
Journal:  Cell       Date:  2007-01-12       Impact factor: 41.582

4.  Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome.

Authors:  Ying Xu; Quasar S Padiath; Robert E Shapiro; Christopher R Jones; Susan C Wu; Noriko Saigoh; Kazumasa Saigoh; Louis J Ptácek; Ying-Hui Fu
Journal:  Nature       Date:  2005-03-31       Impact factor: 49.962

5.  Tissue-specific disruption of rhythmic expression of Dec1 and Dec2 in clock mutant mice.

Authors:  Mitsuhide Noshiro; Masae Furukawa; Sato Honma; Takeshi Kawamoto; Taizo Hamada; Ken-ichi Honma; Yukio Kato
Journal:  J Biol Rhythms       Date:  2005-10       Impact factor: 3.182

6.  Regulation of adaptive behaviour during fasting by hypothalamic Foxa2.

Authors:  Jose P Silva; Ferdinand von Meyenn; Jessica Howell; Bernard Thorens; Christian Wolfrum; Markus Stoffel
Journal:  Nature       Date:  2009-12-03       Impact factor: 49.962

7.  The diurnal rhythm of hypocretin in young and old F344 rats.

Authors:  Frank Desarnaud; Eric Murillo-Rodriguez; Ling Lin; Man Xu; Dmitry Gerashchenko; Samara N Shiromani; Seiji Nishino; Emmanuel Mignot; Priyattam J Shiromani
Journal:  Sleep       Date:  2004-08-01       Impact factor: 5.849

8.  Effects of suvorexant, an orexin receptor antagonist, on sleep parameters as measured by polysomnography in healthy men.

Authors:  Hong Sun; William P Kennedy; Darren Wilbraham; Nicole Lewis; Nicole Calder; Xiaodong Li; Junshui Ma; Ka Lai Yee; Susan Ermlich; Eric Mangin; Christopher Lines; Laura Rosen; Jeffrey Chodakewitz; Gail M Murphy
Journal:  Sleep       Date:  2013-02-01       Impact factor: 5.849

9.  Mice lacking the circadian modulators SHARP1 and SHARP2 display altered sleep and mixed state endophenotypes of psychiatric disorders.

Authors:  Paul C Baier; Magdalena M Brzózka; Ali Shahmoradi; Lisa Reinecke; Christina Kroos; Sven P Wichert; Henrik Oster; Michael C Wehr; Reshma Taneja; Johannes Hirrlinger; Moritz J Rossner
Journal:  PLoS One       Date:  2014-10-23       Impact factor: 3.240

10.  IGFBP3 colocalizes with and regulates hypocretin (orexin).

Authors:  Makoto Honda; Krister S Eriksson; Shengwen Zhang; Susumu Tanaka; Ling Lin; Ahmad Salehi; Per Egil Hesla; Jan Maehlen; Stephanie E Gaus; Masashi Yanagisawa; Takeshi Sakurai; Shahrad Taheri; Kuniaki Tsuchiya; Yutaka Honda; Emmanuel Mignot
Journal:  PLoS One       Date:  2009-01-22       Impact factor: 3.240

View more
  17 in total

Review 1.  Genetics of the human circadian clock and sleep homeostat.

Authors:  Liza H Ashbrook; Andrew D Krystal; Ying-Hui Fu; Louis J Ptáček
Journal:  Neuropsychopharmacology       Date:  2019-08-10       Impact factor: 7.853

Review 2.  The Neurobiological Basis of Sleep and Sleep Disorders.

Authors:  William J Joiner
Journal:  Physiology (Bethesda)       Date:  2018-09-01

Review 3.  Angelman syndrome and melatonin: What can they teach us about sleep regulation.

Authors:  Daniella Buonfiglio; Daniel L Hummer; Ariel Armstrong; John Christopher Ehlen; Jason P DeBruyne
Journal:  J Pineal Res       Date:  2020-10-11       Impact factor: 13.007

Review 4.  Exploring the Therapeutic Potential of Targeting Purinergic and Orexinergic Receptors in Alcoholic Neuropathy.

Authors:  Piyush Madaan; Tapan Behl; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Shivam Yadav; Satvinder Kaur; Saurabh Bhatia; Ahmed Al-Harrasi; Ahmed A H Abdellatif; Ghulam Md Ashraf; Mohamed M Abdel-Daim; Hamad Ghaleb Dailah; Md Khalid Anwer; Simona Bungau
Journal:  Neurotox Res       Date:  2022-01-26       Impact factor: 3.911

Review 5.  The translational neuroscience of sleep: A contextual framework.

Authors:  Michael A Grandner; Fabian-Xosé Fernandez
Journal:  Science       Date:  2021-10-28       Impact factor: 47.728

Review 6.  Genetics of circadian rhythms and sleep in human health and disease.

Authors:  Jacqueline M Lane; Jingyi Qian; Emmanuel Mignot; Susan Redline; Frank A J L Scheer; Richa Saxena
Journal:  Nat Rev Genet       Date:  2022-08-26       Impact factor: 59.581

7.  Familial natural short sleep mutations reduce Alzheimer pathology in mice.

Authors:  Qing Dong; Nicholas W Gentry; Thomas McMahon; Maya Yamazaki; Lorena Benitez-Rivera; Tammy Wang; Li Gan; Louis Ptáček; Ying-Hui Fu
Journal:  iScience       Date:  2022-03-15

8.  The molecular genetics of human sleep.

Authors:  Luoying Zhang; Ying-Hui Fu
Journal:  Eur J Neurosci       Date:  2018-09-20       Impact factor: 3.386

Review 9.  Recent advances in sleep genetics.

Authors:  John M Webb; Ying-Hui Fu
Journal:  Curr Opin Neurobiol       Date:  2020-12-25       Impact factor: 7.070

Review 10.  Orexins, Sleep, and Blood Pressure.

Authors:  Mariusz Sieminski; Jacek Szypenbejl; Eemil Partinen
Journal:  Curr Hypertens Rep       Date:  2018-07-10       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.